知镜 Cognispect · 医学文献与研究工作台

Efficacy of atopic dermatitis alleviation through transcutaneous auricular vagus nerve stimulation in 2,4-dinitrochlorobenzene (DNCB)-induced mouse model.

Lee CM, Shin JH, Song JJ.
Annals of medicine · 2026-06-09 · PMID 42263156

文献摘要

Background Atopic dermatitis (AD) commonly begins in early childhood, and non-pharmacological treatment options remain limited. Vagal cholinergic signaling can modulate immune responses, suggesting a potential role for neuromodulation in inflammatory skin disease. This study investigated whether transcutaneous auricular vagus nerve stimulation (taVNS) alleviates AD-like skin inflammation and whether acetylcholine receptor signaling contributes to its effects. Methods AD-like dermatitis was induced in BALB/c mice using 2,4-dinitrochlorobenzene (DNCB). taVNS (0.2 mA, 15 Hz for 5 min) was applied every 2-3 days for 1 or 2 weeks. Histopathology changes and inflammatory marker expression were assessed in lesional skin. To explore the underlying mechanism, acetylcholine receptor antagonism was used. Results taVNS improved histological features and reduced inflammatory markers compared with DNCB alone. These effects were partially attenuated by acetylcholine receptor antagonism, suggesting involvement of cholinergic signaling, including α7 nicotinic acetylcholine receptors. Conclusion taVNS may be a promising non-invasive adjunctive approach for AD. Its anti-inflammatory effects appear to be associated, at least in part, with cholinergic signaling pathways, warranting further mechanistic and translational studies.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。